EULAR 2022 highlights
EULAR 2022 highlights
September 27, 2022
New Population-based Studies Show Increased Risk of Dementia and Depression in RA
Growing evidence from observational studies indicates that patients with RA have a higher risk of developing dementia. The occurrence of depression is also increased. New research shows depression is linked to increased mortality in this population. Clinically active RA was also associated with an elevated risk of dementia. Further studies are warranted to identify mechanisms of increased risk of dementia in RA patients.
See news release:
Data support the idea of a treatment window in the pre-arthritis phase of early RA
Currently, methotrexate is initiated as first-line treatment when arthritis becomes clinically apparent with joint swelling. However, disease processes begin long before patients develop symptoms. New research published at the 2022 EULAR Congress in Copenhagen suggest that there is potential for a treatment window in the pre-arthritis early phase of RA, where limitations can be just as severe as at the onset of clinical arthritis. But it is also important to consider people’s socioeconomic factors, which may also have a bearing on progression to inflammatory arthritis.
See news release:
Gaming for Adherence to Medication: Using virtual care in RA
Effectiveness of treatment for RA is limited by inadequate adherence. Medication adherence can be influenced by implicit attitudes of personal medication needs and concerns about adverse events. The GAMER study targeted these attitudes using a serious puzzle game.
See news release:
Leave a Reply
You must be logged in to post a comment.